Cancer Moonshot℠ Research Initiatives

Following receipt of the Blue Ribbon Panel (BRP) report, and the authorization of the 21st Century Cures Act, the NCI established implementation teams that align with each of the BRP recommendations. The teams have identified opportunities and developed initiatives for funding that directly address each of the recommendations. These mark the beginning of a Cancer Moonshot portfolio that will continue to be expanded in future years.

The following initiatives have been established to address the goals of the recommendations:

Partnership for Accelerating Cancer Therapies (PACT)

PACT is a five-year, public-private research collaboration launched by NIH and 11 pharmaceutical companies. As part of this effort, NCI recently awarded grants to support four Cancer Immune Monitoring and Analysis Centers (CIMACs) and a Cancer Immunologic Data Commons (CIDC).

Learn how PACT will accelerate the development of new cancer immunotherapy strategies for more patients.

  • Updated: November 5, 2018

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Moonshot℠ Research Initiatives was originally published by the National Cancer Institute.”

We welcome your comments on this post. All comments must follow our comment policy.